Intriguingly, an association between the prevalence of severe tetracycline-treated acne and increased risk of prostate cancer later in life has been observed [20]
The STEP trials (published 2021-2022) enrolled over 4,500 participants
GLP-1 RAs such as dulaglutide and liraglutide may lower the risk of depressive and anxiety symptoms in diabetic populations, particularly with prolonged use
Garcia JP, Wortmann CS, Mamo M, Drijber R, Tarkalson D (2007) One-time tillage of no-till: Effects on nutrients, mycorrhizae, and phosphorus uptake
Studies suggest that advances in peptide synthesis and delivery mechanisms may improve research applications and experimental specificity
Event Phase 2 Rate (12 mg group) Phase 2 Rate (Placebo) Nausea 45.8% 11.6% Diarrhea 33.3% 9.3% Vomiting 22.2% 2.3% Constipation 16.7% 7.0% Decreased appetite 22.2% 2.3% The nausea incidence at the highest dose a nausea percentage of roughly 46% makes it the single most reported adverse event in retatrutide clinical trials 2026 data